0460:HKG
Sihuan Pharmaceutical Holdings Group Ltd
HK$0.78
arrow_upward
+2.61%(+0.020) 1D
Sep 4, 4:08:01 PM GMT+8 · HKD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0460...
Open
HK$0.78
High
HK$0.80
Low
HK$0.78
Mkt. cap
7.16B
Avg. vol.
0.00
Volume
26.07M
Dividend
2.78%
Quarterly dividend
HK$0.01
Ex-dividend date
Jun 30, 2026
P/E ratio
20.15
52-wk high
HK$1.92
52-wk low
HK$0.74
EPS
HK$0.04
Shares outstanding
9.47B
No. of employees
3K
Open
HK$0.78
High
HK$0.80
Low
HK$0.78
Mkt. cap
7.16B
Avg. vol.
0.00
Volume
26.07M
Dividend
2.78%
Quarterly dividend
HK$0.01
Ex-dividend date
Jun 30, 2026
P/E ratio
20.15
52-wk high
HK$1.92
52-wk low
HK$0.74
EPS
HK$0.04
Shares outstanding
9.47B
No. of employees
3K
News stories
From web sources and news partners
Profile
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market.
Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
About Sihuan Pharmaceutical Holdings Group Ltd
CEOGuo Weicheng
Employees2.71K
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitesihuanpharm.com